Journals / Anatolian Current Medical Journal / 2020 / Cilt: 2 - Sayı: 3

Inflammatory bowel diseases and genetic

İnflamatuvar barsak hastalıkları ve genetik

Pages
80–86
Publication Date
2020-06-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Unfortunately, with the latest developments, genetic changes that play a role in the emergence of the disease have not been limited to these;nonfunctional genes, epigenetic changes, metabolomics and many other conditions have been shown to be associated with inflammatory bowel diseases.Despite all these developments, the fact that the pathogenesis of the disease has not been clearly revealed is due to its multifactorial nature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Inflammatory bowel diseases are a group of chronic inflammatory diseases that involve the gastrointestinal tract.
📊
Key Findings & Data:While the etiology of inflammatory boweldiseases is still not elucidated, an exaggerated immune response to luminal content is thought to occur in the intestinal tract as a result of the complexinteraction of environmental and genetic factors.
💡
Conclusion & Impact:Unfortunately, with the latest developments, genetic changes that play a role in the emergence of the disease have not been limited to these;nonfunctional genes, epigenetic changes, metabolomics and many other conditions have been shown to be associated with inflammatory bowel diseases.Despite all these developments, the fact that the pathogenesis of the disease has not been clearly revealed is due to its multifactorial nature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İnflamatuvar barsak hastalıkları · genetik · JAK-STAT yolağı

Abstract

Inflammatory bowel diseases are a group of chronic inflammatory diseases that involve the gastrointestinal tract. While the etiology of inflammatory boweldiseases is still not elucidated, an exaggerated immune response to luminal content is thought to occur in the intestinal tract as a result of the complexinteraction of environmental and genetic factors. This reaction may occur as a result of loss of immune-tolerance to luminal antigens in those who aregenetically susceptible. Today, a large number of genes have been identified that are susceptible to inflammatory bowel diseases that may affect the intestinalimmune response. These occur in relation to effective mechanisms at different stages of the intestinal immune system. Genetic changes that may occur inmany layers of the intestinal immune system, including luminal microbiota, intestinal epithelial barrier, antigen identification, autophagy and infamazom,endoplasmic reticulum stress, antigen presentation and acquired immune system, and JAK-STAT pathway, will affect the functioning of the system. will causeit to come to light. Unfortunately, with the latest developments, genetic changes that play a role in the emergence of the disease have not been limited to these;nonfunctional genes, epigenetic changes, metabolomics and many other conditions have been shown to be associated with inflammatory bowel diseases.Despite all these developments, the fact that the pathogenesis of the disease has not been clearly revealed is due to its multifactorial nature.

Özet

İnflamatuvar barsak hastalıkları gastrointestinal sistemi tutan kronik inflamatuvar bir hastalık grubudur. İnflamatuvar barsak hastalıklarının etiyolojisi hala aydınlatılamamışken, çevresel ve genetik faktörlerin kompleks etkileşimi sonucu, intestinal sistemde lüminal içeriğe karşı abartılı bir immün yanıtın oluştuğu düşünülmektedir. Bu reaksiyon, genetik olarak yatkın olanlarda lüminal antijenlere karşı immün-toleransın kaybolması sonucu meydana geliyor olabilir. Günümüzde, İnflamatuvar barsak hastalıkları için yatkınlık oluşturan, intestinal immün yanıtı etkileyebilecek çok sayıda gen tanımlanmıştır. Bunlar intestinal immün sistemin farklı basamaklarında etkili mekanizmalarla ilişkili olarak ortaya çıkmaktadır. İntestinal immün sistemin, lüminal mikrobiyota, intestinal epitelyal bariyer, antijen tanımlama, otofaji ve inflamazom, endoplazmik retikulum stresi, antijen sunumu ve kazanılmış bağışıklık sistemi ile JAK-STAT yolağını da içine alan birçok katmanında genetik olarak ortaya çıkabilecek değişiklikler sistemin işleyişinin etkilenmesine neden olacak, hastalığın gün yüzüne çıkmasına neden olacaktır. Ama maalesef son gelişmelerle birlikte hastalığın ortaya çıkmasında rol oynayan genetik değişikliklerin bunlarla sınırlı olmadığı, nonfonksiyone genler, epigenetik değişiklikler, metabolomikler ve bunun gibi birçok durumun da inflamatuvar barsak hastalıklarıyla ilişkisi gösterilmiştir. Bütün bu gelişmelere rağmen hala daha hastalığın patogenezi net birşekilde ortaya konulamamış olması, hastalığı multifaktöryel doğasından kaynaklanmaktadır.

🔖

Cite This Article

CAN, G., TEZEL, H. A. (2020). Inflammatory bowel diseases and genetic. Anatolian Current Medical Journal, Cilt: 2 - Sayı: 3, 80–86. https://ajindex.com/articles/733885

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterol 1998; 115: 182-205
  2. Editorial: Wilhelm Fabry (1560–1624): the other fabricius. JAMA 1964; 190: 933
  3. Crohn B, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932: regional ileitis: a pathological and clinical entity, by Burril B Crohn, Leon Ginzburg, and Gordon D Oppenheimer. JAMA 1984; 251: 73–9
  4. Wilks S. Morbid appearances in the intestine of Miss Bankes. London Medical Times & Gazette 1859; 2: 264
  5. Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ? World J Gastroenterol 2006; 12: 1829-41
  6. Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Farkkila M, Kontula K. Family and twin studies in inflammatory bowel disease. World J Gastroenterol 2006; 12: 3668-72
  7. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661–78
  8. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-3
  9. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-17
  10. Satsangi J, Grootscholten C, Holt H, Jewel DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996: 38; 738-41
  11. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008; 14: 968–76
  12. Bengtson MB, Solberg C, Aamodt G, et al. Clustering in time of familial IBD separates ulcerative colitis from Crohn’s disease. Inflamm Bowel Dis 2009; 15: 1867–74
  13. Orholm M, Binder V,Sorensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins: results of a nationwide study. Scand J Gastroenterol 2000; 35: 1075-81
  14. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001; 411: 599-603
  15. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001; 411: 603-6
  16. Hampe J, Schreiber S, Shaw SH, Let al. A genom wide analysis provid